HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[ACTH-secreting tumors. Deregulation of the proopiomelanocortin gene and alterations in processing].

Abstract
ACTH is produced by proteolysis of a polypeptide precursor, proopiomelanocortin (or POMC). Various POMC-derived peptides are cosecreted with ACTH. Analysis of the ACTH--and its "satellite" peptides--molecular forms establishes the POMC "maturation profile" in different tissues. This profile is identical in normal and tumoral pituitaries (Cushing's disease and/or Nelson's syndrome). It is often altered in non-pituitary tumors responsible for the ectopic ACTH syndrome: abnormal peptides may be generated (CLIP h beta MSH5-22) which can be detected in blood. Analysis of POMC gene transcription in pituitary tumors shows no abnormality. In some non-pituitary tumors the activation of upstream promoters up to 369 nucleotides from the normal (pituitary) transcription initiation site can be shown. In normal non-pituitary tissues a third type of transcription is observed generating a short and probably non-functional messenger RNA limited to a portion of the gene non-coding region.
AuthorsX Bertagna, Y De Keyzer, A Kahn, F Girard, J P Luton
JournalAnnales d'endocrinologie (Ann Endocrinol (Paris)) Vol. 49 Issue 4-5 Pg. 374-6 ( 1988) ISSN: 0003-4266 [Print] France
Vernacular TitleLes tumeurs ACTH sécrétantes. Dérégulation du gène de la proopiomélanocortine et pathologie de la maturation.
PMID2849366 (Publication Type: Journal Article, Review)
Chemical References
  • Hormones, Ectopic
  • Peptide Fragments
  • RNA, Messenger
  • Pro-Opiomelanocortin
  • Adrenocorticotropic Hormone
Topics
  • Adrenal Gland Neoplasms (genetics)
  • Adrenocorticotropic Hormone (metabolism)
  • Gene Expression Regulation
  • Hormones, Ectopic (metabolism)
  • Humans
  • Immunologic Techniques
  • Peptide Fragments (immunology)
  • Pheochromocytoma (genetics)
  • Pro-Opiomelanocortin (genetics)
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: